US Patent Issued to Merck Sharp & Dohme on July 14 for "Modified isoindolinones as glucosylceramide synthase inhibitors" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,807, issued on July 14, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Modified isoindolinones as glucosylceramide synthase inhibitors" was invented by Michael J. Breslin (Drexel Hill, Pa.), Mark E. Fraley (North Wales, Pa.), H. Marie Loughran (Perkasie, Pa.), James J. Mulhearn (Elkins Park, Pa.), Anthony J. Roecker (Harleysville, Pa.), Kathy M. Schirripa (Harleysville, Pa.) and Shawn J. Stachel (Perkasie, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of Formula (I): and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at leas...